Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029052945> ?p ?o ?g. }
- W2029052945 endingPage "155" @default.
- W2029052945 startingPage "147" @default.
- W2029052945 abstract "The recent approval by the FDA of cancer vaccines and drugs that blockade immunological negative regulators has further enhanced interest in promising approaches of the immunotherapy of cancer. However, the disappointingly short life extension has also underscored the need to better understand the mechanisms that prevent tumor rejection and survival even after the blockade of immunological negative regulators. Here, we describe the implications of the metabolism-based immunosuppressive mechanism, where the local tissue hypoxia-driven accumulation of extracellular adenosine triggers suppression via A2 adenosine receptors on the surface of activated immune cells. This molecular pathway is of critical importance in mechanisms of immunosuppression in inflamed and cancerous tissue microenvironments. The protection of tumors by tumor-generated extracellular adenosine and A2 adenosine receptors could be the misguided application of the normal tissue-protecting mechanism that limits excessive collateral damage to vital organs during the anti-pathogen immune response. The overview of the current state of the art regarding the immunosuppressive effects of extracellular adenosine is followed by a historical perspective of studies focused on the elucidation of the physiological negative regulators that protect tissues of vital organs from excessive collateral damage, but, as a trade-off, may also weaken the anti-pathogen effector functions and negate the attempts of anti-tumor immune cells to destroy cancerous cells." @default.
- W2029052945 created "2016-06-24" @default.
- W2029052945 creator A5012156971 @default.
- W2029052945 creator A5076187024 @default.
- W2029052945 date "2013-01-20" @default.
- W2029052945 modified "2023-09-23" @default.
- W2029052945 title "Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer" @default.
- W2029052945 cites W146968556 @default.
- W2029052945 cites W1482654523 @default.
- W2029052945 cites W1496188050 @default.
- W2029052945 cites W1516902820 @default.
- W2029052945 cites W1526801414 @default.
- W2029052945 cites W1536831250 @default.
- W2029052945 cites W1572273862 @default.
- W2029052945 cites W1593467689 @default.
- W2029052945 cites W1608041394 @default.
- W2029052945 cites W161060649 @default.
- W2029052945 cites W1799143857 @default.
- W2029052945 cites W1881296535 @default.
- W2029052945 cites W1969233019 @default.
- W2029052945 cites W1973206036 @default.
- W2029052945 cites W1974409640 @default.
- W2029052945 cites W1975614861 @default.
- W2029052945 cites W1977187462 @default.
- W2029052945 cites W1979406691 @default.
- W2029052945 cites W1979942820 @default.
- W2029052945 cites W1981552113 @default.
- W2029052945 cites W1982767795 @default.
- W2029052945 cites W1983934270 @default.
- W2029052945 cites W1984270170 @default.
- W2029052945 cites W1985598247 @default.
- W2029052945 cites W1988951550 @default.
- W2029052945 cites W1990113288 @default.
- W2029052945 cites W1990318519 @default.
- W2029052945 cites W2001312442 @default.
- W2029052945 cites W2002250199 @default.
- W2029052945 cites W2012461372 @default.
- W2029052945 cites W2013616623 @default.
- W2029052945 cites W2014275356 @default.
- W2029052945 cites W2015221768 @default.
- W2029052945 cites W2020818950 @default.
- W2029052945 cites W2021609949 @default.
- W2029052945 cites W2025284540 @default.
- W2029052945 cites W2025975691 @default.
- W2029052945 cites W2029733235 @default.
- W2029052945 cites W2036018074 @default.
- W2029052945 cites W2036205982 @default.
- W2029052945 cites W2043029488 @default.
- W2029052945 cites W2043281436 @default.
- W2029052945 cites W2043904711 @default.
- W2029052945 cites W2049268565 @default.
- W2029052945 cites W2052874737 @default.
- W2029052945 cites W2056825692 @default.
- W2029052945 cites W2056959697 @default.
- W2029052945 cites W2057556028 @default.
- W2029052945 cites W2061178426 @default.
- W2029052945 cites W2062761137 @default.
- W2029052945 cites W2065576227 @default.
- W2029052945 cites W2074844667 @default.
- W2029052945 cites W2076301973 @default.
- W2029052945 cites W2077703512 @default.
- W2029052945 cites W2077786296 @default.
- W2029052945 cites W2080748790 @default.
- W2029052945 cites W2080942561 @default.
- W2029052945 cites W2082083390 @default.
- W2029052945 cites W2087167599 @default.
- W2029052945 cites W2087391162 @default.
- W2029052945 cites W2088029302 @default.
- W2029052945 cites W2088084884 @default.
- W2029052945 cites W2089916504 @default.
- W2029052945 cites W2091246599 @default.
- W2029052945 cites W2092681867 @default.
- W2029052945 cites W2097354544 @default.
- W2029052945 cites W2097478351 @default.
- W2029052945 cites W2102478114 @default.
- W2029052945 cites W2106190040 @default.
- W2029052945 cites W2108972938 @default.
- W2029052945 cites W2110191141 @default.
- W2029052945 cites W2111736575 @default.
- W2029052945 cites W2116238347 @default.
- W2029052945 cites W2121815506 @default.
- W2029052945 cites W2123797012 @default.
- W2029052945 cites W2125075553 @default.
- W2029052945 cites W2132604760 @default.
- W2029052945 cites W2134245211 @default.
- W2029052945 cites W2136798443 @default.
- W2029052945 cites W2139076091 @default.
- W2029052945 cites W2141956613 @default.
- W2029052945 cites W2141975557 @default.
- W2029052945 cites W2142935448 @default.
- W2029052945 cites W2147934896 @default.
- W2029052945 cites W2150213518 @default.
- W2029052945 cites W2152701856 @default.
- W2029052945 cites W2157940881 @default.
- W2029052945 cites W2158419561 @default.
- W2029052945 cites W2161546085 @default.
- W2029052945 cites W2163178183 @default.
- W2029052945 cites W2163202117 @default.